Novel 3-hydroxy-5-arylisoxazole derivative

Details for Australian Patent Application No. 2010312365 (hide)

Owner Mochida Pharmaceutical Co.,Ltd.

Inventors Okano, Akihiro; Ohkouchi, Munetaka

Agent Spruson & Ferguson

Pub. Number AU-A-2010312365

PCT Pub. Number WO2011/052756

Priority 2009-281014 10.12.09 JP; 2009-251493 30.10.09 JP

Filing date 29 October 2010

Wipo publication date 5 May 2011

International Classifications

C07D 261/12 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/052756 Priority application(s): WO2011/052756

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010312371-Method for producing organic solvent dispersion of inorganic oxide microparticles

2010312335-Device for compressing and drying gas and a method applied thereby.